Results 71 to 80 of about 5,655 (219)

Treatment for papillary thyroid microcarcinoma

open access: yesWspółczesna Onkologia, 2013
The treatment for papillary thyroid microcarcinoma (PTMC), which is a tumor measuring less than 1 cm, is still a subject of controversy. The aim of this study is to retrospectively evaluate the patients diagnosed with PTMC in terms of their clinical and histopathological features.A total of 153 consecutive patients with PTMC were treated, and their ...
Shi, Lan   +4 more
openaire   +2 more sources

Five Advances in the Last 50 Years That Have Impacted Endocrine Surgery

open access: yes
World Journal of Surgery, EarlyView.
Matilda Anneback   +5 more
wiley   +1 more source

Correlation of Fine Needle Aspiration Cytology and Histopathology in Thyroid Nodules: A Six‐Year Study at a Tertiary Public Laboratory in the Western Cape Province, South Africa

open access: yesDiagnostic Cytopathology, Volume 54, Issue 5, Page 359-370, May 2026.
ABSTRACT Background Fine‐needle aspiration cytology (FNAC) is the primary screening test for thyroid nodules. The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) provides six diagnostic categories, each with an implied risk of malignancy (ROM). This study evaluated the performance of thyroid FNAC and the application of TBSRTC categories in
Raymond Chimatira, Brendon Price
wiley   +1 more source

Frequency of Thyroid Microcarcinoma in Patients Who Underwent Total Thyroidectomy with Benign Indication—A 5-Year Retrospective Review

open access: yesMedicina
Background and Objectives: Incidental thyroid cancers (ITCs) are often microcarcinomas. The most frequent histologic type is a papillary microcarcinoma. Papillary thyroid microcarcinomas are defined as papillary thyroid tumours measuring less than 10 mm ...
Vasiliki Magra   +10 more
doaj   +1 more source

Importance of ELABELA in the differential diagnosis of benign and malignant lesions of the thyroid gland

open access: yesArchives of Endocrinology and Metabolism, 2020
Objective: This study investigated whether ELABELA plays a role in the differential diagnosis of benign and malignant lesions of the thyroid gland. Subjects and methods: Of the 87 patients included in the study, 12 had undergone surgery for benign ...
Mehmet Bankir   +2 more
doaj   +1 more source

Immunotherapy in Thyroid Cancer: Current Strategies and Challenges

open access: yesCancer Medicine, Volume 15, Issue 4, April 2026.
ABSTRACT Thyroid cancer is the most common endocrine malignancy, with an increasing global incidence. Despite advances in conventional treatments, such as surgery, radioactive iodine therapy, and TSH suppression, the management of advanced and aggressive forms, such as anaplastic thyroid carcinoma and refractory differentiated thyroid carcinoma ...
Qian Zhang   +5 more
wiley   +1 more source

Fibrosis‐Driven Surgical Risk After Thyroid Nodule Ablation: Quantitative Clinicopathological Determinants of Complications in Post‐Ablative Thyroidectomy—A Retrospective Cohort Study

open access: yesWorld Journal of Surgery, Volume 50, Issue 4, Page 914-923, April 2026.
Thermal ablation is increasingly used for selected benign and low‐risk thyroid nodules, yet some patients still require thyroidectomy for regrowth, persistent symptoms, or new oncologic concern. The surgical and pathological impact of ablation‐induced remodeling remains incompletely defined.
Daqi Zhang   +7 more
wiley   +1 more source

Is radioiodine administration in patients with papillary thyroid multifocal microcarcinoma unnecessary?

open access: yesEndocrinology, Diabetes & Metabolism Case Reports, 2016
Radioiodine (RAI) has played a crucial role in differentiated thyroid cancer treatment for more than 60years. However, the use of RAI administration in patients with papillary thyroid microcarcinoma (even multifocal) is now being widely discussed and ...
Eva Krčálová   +8 more
doaj   +1 more source

Active surveillance of thyroid microcarcinomas [PDF]

open access: yesArchives of Endocrinology and Metabolism, 2019
There is a recent trend in the thyroid cancer literature towards a more conservative approach to papillary microcarcinomas of the thyroid gland. The widespread acceptance of lobectomy as adequate treatment for most patients is part of this tendency. Undoubtedly, the most conservative attitude concerning these indolent cancers is the active surveillance,
openaire   +4 more sources

Thyroglobulin Autoantibodies Do Not Influence the Outcome of Patients With Differentiated Thyroid Carcinoma

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 2, March 2026.
Thyroglobulin autoantibodies (TgAb) occur in roughly 25% of thyroid cancer patients and interfere with Tg measurement. Our study shows TgAb presence does not affect patient outcomes, but close monitoring is essential to avoid overtreatment. ABSTRACT Introduction Thyroglobulin (Tg) is a sensitive and specific marker for differentiated thyroid carcinoma (
C. Bornemann, C. Bouter
wiley   +1 more source

Home - About - Disclaimer - Privacy